IMB’s Centre for Inflammation and Disease Research (CIDR) is based at The University of Queensland in Brisbane, Australia. CIDR brings together basic research with drug discovery to develop new therapeutics and diagnostics for inflammation-related diseases.
Inflammation is a normal bodily process necessary for healing and for fighting infections. Unfortunately, uncontrolled inflammation contributes to many acute and chronic medical conditions and diseases. These diseases — such as arthritis, asthma, cancer, diabetes, hepatitis and inflammatory bowel disease — affect a huge number of people in our community and the associated health costs continue to rise.
To tackle this growing problem, IMB’s Centre for Inflammation and Disease Research (CIDR) is identifying pathways in the body that control inflammation.
Our aim is to understand inflammation at the cellular and molecular level, and devise strategies to track and control inflammation to prevent or treat disease.
Our mission is to develop innovative approaches for characterizing molecular and cellular processes of inflammation, as well as disease mechanisms.
Our vision is to discover and develop new drugs, diagnostics and therapeutics to improve the health of our community.
I encourage you to explore our website to learn more about our research in this important area of medical research, and how you can help us to make a difference.